Conversely, BRD7 levels in NPC tissues were lower than in noncancerous NP tissues, and BRD7 expression in clinical stages III and IV was significantly lower than that in stages I and II, consistent with the previous results (Table 1, Fig. 8A, B). This evidence concerns the gene BRD7 and nasopharyngeal carcinoma.